Testosterone topical Tostrex - ProStrakan

Drug Profile

Testosterone topical Tostrex - ProStrakan

Alternative Names: EN3350; Fortesta; Fortigel; Itnogen; Tostran; Tostrex

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Cellegy Pharmaceuticals
  • Developer Kyowa Kirin International
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Hypogonadism

Highest Development Phases

  • Marketed Hypogonadism

Most Recent Events

  • 23 Jan 2015 Biomarkers information updated
  • 08 Sep 2014 First Generic equivalent available in USA for Hypogonadism
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top